The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.
Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, will present at the Redeye Technology & Life Science Day on December 3, hosted by Redeye.
Qu emphasized that food security is fundamental to human survival and development. He highlighted the need to further leverage nuclear technology in advancing food security efforts, to tackle global ...